CXCR5 and B-cell chronic lymphocytic leukemia: Since CLL is characterized by an acquired T‐cell dysfunction, CXCR5+PD‐1+ CD8 T cells may also be functionally impaired in CLL, which could be an explanation for reduced response rate to PD‐1 ICB [14, 15, 16, 17].